Tumor marker disaccharide D-Gal-β1,3-GalNAc complexed to heat-labile enterotoxin from Escherichia coli

Protein Science

Volumn 5, Issue 6, 1996, Pages 1184-1188

  Van Den Akker, Focco ^a   Steensma, Elles ^b,c   Hol, Wim G J ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

carbohydrate interactions; cholera toxin family; ganglioside G(M1); Thomsen Friedenreich antigen; tumor antigen; X ray crystallography

Indexed keywords

ANTINEOPLASTIC AGENT; CHOLERA TOXIN; DISACCHARIDE; ESCHERICHIA COLI ENTEROTOXIN; GALACTOSE; GANGLIOSIDE GM1; HYDROGEN; OLIGOSACCHARIDE; RECEPTOR; TUMOR ANTIGEN; TUMOR MARKER;

ARTICLE; BINDING SITE; CARCINOMA; CRYSTAL STRUCTURE; DRUG DELIVERY SYSTEM; HYDROGEN BOND; IMMUNE RESPONSE; PRIORITY JOURNAL; X RAY CRYSTALLOGRAPHY;

ESCHERICHIA COLI;

EID: 0030011313     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560050621     Document Type: Article

References (26)

1. Bray J, MacLean GD, Dusel FJ, McPherson TA. 1982. Decreased levels of circulating lytic anti-T in the serum of patients with metastatic gastrointestinal cancer: A correlation with disease burden Clin Exp Immunol 47:176-182.
2. Brünger AT, Kuriyan J, Karplus M. 1987. Crystallographic R factor refinement by molecular dynamics. Science 235:458-460.
3. Jobling MG, Holmes RK. 1991. Analysis of structure and function of the B subunit of cholera toxin by the use of site-directed mutagenesis. Mol Microbiol 5:1755-1767.
4. Jones TA, Zou JY, Cowan SW, Kjeldgaard M. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A 47:110-119.
5. Kraulis PJ. 1991. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr 24:946-950.
6. Lotan R, Skutelsky E, Danon D, Sharon N. 1975. The purification, composition, and specificity of the anti-T lectin from peanut (Arachis hypogaea). J Biol Chem 250:8518-8523.
7. MacLean GD, Longenecker BM. 1991. Clinical significance of the Thomsen-Friedenreich antigen. Semin Cancer Biol 2:433-439.
8. Merritt EA, Murphy MEP. 1994. Raster3D, version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr D 50:869-873.
9. Merritt EA, Sarfaty S, Chang TT, Palmer LM, Jobling MG, Holmes RK, Hol WGJ. 1995. Surprising leads for a cholera toxin receptor-binding antagonist: Crystallographic studies of CTB mutants. Structure 3:561-570.
10. M1 pentasaccharide. Protein Sci 3:166-175.
11. Merritt EA, Sixma TK, Kalk KH, van Zanten BAM, Hol WGJ 1994b. Galactose-binding site in Escherichia coli heat-labile enterotoxin (LT) and cholera toxin (CT). Mol Microbiol 13:745-753.
12. Pai LH, Batra JK, FitzGerald DJ, Willingham MC, Pastan I. 1991. Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin Proc Natl Acad Sci USA 83: 3358-3362.
13. Pai LH, FitzGerald DJ, Tepper M, Schacter B, Spitalny G, Pastan I. 1990. Inhibition of antibody response to Pseudomonas exotoxin and an immunotoxin containing Pseudomonas exotoxin by 15-deoxyspergualin in mice. Cancer Res 50:7750-7753.
14. Pastan I, Chaudhary V, FitzGerald DJ. 1992. Recombinant toxins as novel therapeutic agents. Annu Rev Biochem 61:331-354.
15. Pereira MEA, Kabat EA, Lotan R, Sharon N. 1976. Immunochemical studies on the specificity of the peanut (Arachis hypogaea) agglutinin. Carbohydr Res 51:107-118.
16. Pronk SE, Hofstra H, Groendjjk H, Kingma J, Swarte MBA, Dorner F, Drenth J, Hol WGJ, Witholt B. 1985. Heat-labile enterotoxin of Escherichia coli. Characterization of different crystal forms. J Biol Chem 260:13580-13584.
17. Schlepper-Schäfer J, Springer GF. 1989. Carcinoma autoantigens T and Tn and their cleavage products interact with Gal/GalNAc-specific receptors on rat Kupffer cells and hepatocytes. Biochim Biophys Acta 1013:266-212.
18. Sixma TK, Pronk SE, Kalk KH, van Zanten BAM, Berghuis AM, Hol WGJ. 1992. Lactose binding to heat-labile enterotoxin revealed by X-ray crystallography. Nature 355:561-564.
19. Springer GF. 1984. T and Tn, general carcinoma autoantigens. Science 224:1198-1206.
20. Springer GF, Cheingsong-Popov R, Schirrmacher V, Desai PR, Tegtmeyer H. 1983. Proposed molecular basis of murine tumor cell-hepatocyte interaction. J Biol Chem 258:5702-5706.
21. Springer GF, Desai PR, Tegtmeyer H, Carlstedt SC, Scanlon EF. 1994. T/Tn antigen vaccine is effective and safe in preventing recurrence of advanced human breast carcinoma. Cancer Biother 9:7-15.
22. Springer GF, Desai PR, Tegtmeyer H, Spencer BD, Scanlon EF. 1993. Pancarcinoma T/Tn antigen detects human carcinomas long before biopsy does and its vaccine prevents breast carcinoma recurrence. Ann NY Acad Sci 690:355-357.
23. Springer GF, Desai PR, Wise W, Carlstedt SC, Tegtmeyer H, Stein R, Scanlon EF. 1990. Pancarcinoma T and Tn epitopes: Autoimmunogens and diagnostic markers that reveal incipient carcinomas and help establish prognosis. Immunol Ser 53:587-612.
24. Thatcher N, Hashmi K, Chang J, Swindell R, Crowther D. 1980. Anti-T antibody in malignant melanoma patients. Cancer 46:1378-1382.
25. Van Heyningen WE, Carpenter CCJ, Pierce NF, Greenough WB. 1971. Deactivation of cholera toxin by ganglioside. J Infect Dis 124:415-418.
26. Vos GH, Brain P. 1981. Heterophite antibodies, immunoglobulin levels, and the evaluation of anti-T activity in cancer patients and controls. S Afr Med J 60:133-136.